Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CRISPR-based therapeutics: current challenges and future applications

Trends in Pharmacological Sciences(2021)10.1016/j.tips.2021.10.012Source: DataRank Database

CRISPR-based therapeutics: current challenges and future applications is a research paper published in Trends in Pharmacological Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 102 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access102 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: greenTopics (13)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Donghyun Lim ORCID,Tuan M. Nguyen ORCID,Vedagopuram Sreekanth ORCID,Amit Choudhary ORCID,Ashley E. Modell ORCID

Live enrichment

PubMed:34952739 PMC:PMC9726229

National Institutes of Health

Grant: R01GM132825

National Institutes of Health

Grant: R01GM137606

Defense Advanced Research Projects Agency

Grant: N66001-17-2-4055

Broad Institute

Grant: 2020/0354701

Broad Institute

Grant: 2021/0139872

Broad Institute

Grant: 2021/0222164

Broad Institute

Grant: WO 2020/041380

Broad Institute

Grant: WO 2020/041384

National Institute of Health

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9726229

publisherhttps://api.elsevier.com/content/article/PII:S0165614721002157?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0165614721002157?httpAccept=text/plain

Fields of Study

CRISPR-Cas SystemsGene EditingGenetic TherapyHumans

MeSH Terms

HumansGenetic TherapyCRISPR-Cas SystemsGene Editing

Keywords

Genome EngineeringCrispr-cas9Cell-based TherapeuticsBase EditingPrime Editing

Related Papers (10)

Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis

Science(2020)

co-cited

10.1126/science.aay0939

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies

Cancer Cell(2020)

co-cited

10.1016/j.ccell.2020.05.004

Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities

N/A

0.574DataRank · unranked

Cancer Discovery(2020)

co-cited

10.1158/2159-8290.cd-19-1274

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target

Cell(2021)

co-cited

10.1016/j.cell.2021.09.006

Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer

Molecular Cell(2021)

co-cited

10.1016/j.molcel.2021.06.014

ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells

Nature Cell Biology(2021)

co-cited

10.1038/s41556-020-00624-3

Genomic Alterations in PIK3CA -Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors

Cancer Research(2021)

co-cited

10.1158/0008-5472.can-20-3232

Systematic functional interrogation of human pseudogenes using CRISPRi

Genome biology(2021)

co-cited

10.1186/s13059-021-02464-2

Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen

Molecular Oncology(2021)

co-cited

10.1002/1878-0261.12951

High-content CRISPR screening

N/A

6.0DataRank · unranked

Nature Reviews Methods Primers(2022)

co-cited

10.1038/s43586-022-00098-7

CRISPR-based therapeutics: current challenges and future applications

FAIR Checklist

Authors (5)

Funding (9 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (10)